Login Register Cart 0
Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Protective Effects of Omega-3 Fatty Acids Supplementation Against Renal Parenchymal Scarring in Children with Acute Pyelonephritis: Results of a Pilot Clinical Trial

Author(s): Iraj Sedighi, Ghazal Taheri-Moghadam, Hossein Emad-Momtaz, Golnaz Vaseghi, Azadeh Eshraghi, Farzaneh Asnaashari and Maryam Mehrpooya*

Volume 18, Issue 1, 2022

Published on: 21 December, 2021

Page: [72 - 81] Pages: 10

DOI: 10.2174/1573396317666210909153643

Price: $65

Abstract

Aim: This trial aimed to determine if supplementation with omega-3 fatty acids as an adjunct therapy to antibiotic treatment can have protective effects against renal scar formation after acute pyelonephritis (APN) in pediatric patients.

Background: Current evidence points out that besides antibiotic treatment, early administration of antioxidant and anti-inflammatory compounds may be effective in reducing the occurrence of renal damage following APN in children.

Objective: The main endpoint of the trial was the comparison of the development of renal scarring formation after APN in an omega-3 fatty acids-treated group and in a control-treated group.

Methods: This prospective randomized, controlled trial study was conducted from March 2016 to May 2018 on 60 children with a diagnosis APN in a tertiary hospital in Iran. After the diagnosis of APN based on the clinical signs and symptoms, urine analysis, urine culture, and dimercaptosuccinic acid renal scan (DMSA scan), the patients were randomly allocated into either the control group (n=30 patients: received standard antibiotic treatment only) or the intervention group (n=30 patients: received standard antibiotic-treatment in combination with oral omega-3 fatty acids based on the children’s weight for three consecutive days). A second DMSA scan was performed for the patients at a minimum of six months after treatment. The development of renal scars was evaluated by comparing the baseline DMSA scan lesions with the follow-up DMSA scan lesions.

Results: Fifty patients, including 26 and 24 individuals in the control and intervention groups, respectively, completed the entire course of the study. Renal parenchymal involvement based on the baseline DMSA scan was similar in the two groups (p-value =0.85, 0.90, and 0.53 regarding the right, left, and both kidney units together, respectively). Although comparison of the follow-up DMSA scan lesions to the baseline DMSA scan lesions considering the right and left kidneys as separate units between two groups did not reach the significant level, when considering both left and right kidney units together, results showed a statistically significant difference between groups in favor of the intervention group (p-value =0.04).

Conclusion: Although preliminary, the results of this study showed that administration of omega-3 fatty acids, a natural supplement with well-known anti-inflammatory and antioxidant properties, as an adjunct therapy to standard antibiotic treatment might significantly reduce the incidence of the occurrence renal scarring following APN in children. Confirmation of these results requires further studies.

Keywords: Pyelonephritis, omega-3 fatty acids, anti-inflammatory supplement, antioxidant agents, renal scarring formation, DMSA scan.

« Previous
Graphical Abstract

[1]
Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003; 49(2): 53-70.
[http://dx.doi.org/10.1067/mda.2003.7] [PMID: 12601337]
[2]
Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 2008; 27(4): 302-8.
[http://dx.doi.org/10.1097/INF.0b013e31815e4122] [PMID: 18316994]
[3]
Hoberman A, Chao H-P, Keller DM, Hickey R, Davis HW, Ellis D. Prevalence of urinary tract infection in febrile infants. J Pediatr 1993; 123(1): 17-23.
[http://dx.doi.org/10.1016/S0022-3476(05)81531-8] [PMID: 8320616]
[4]
Shaw KN, Gorelick M, McGowan KL, Yakscoe NM, Schwartz JS. Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics 1998; 102(2): 16.
[http://dx.doi.org/10.1542/peds.102.2.e16]
[5]
Tandogdu Z, Wagenlehner FM. Global epidemiology of urinary tract infections. Curr Opin Infect Dis 2016; 29(1): 73-9.
[http://dx.doi.org/10.1097/QCO.0000000000000228] [PMID: 26694621]
[6]
Lee M-D, Lin C-C, Huang F-Y, Tsai T-C, Huang C-T, Tsai J-D. Screening young children with a first febrile urinary tract infection for high-grade vesicoureteral reflux with renal ultrasound scanning and technetium-99m-labeled dimercaptosuccinic acid scanning. J Pediatr 2009; 154(6): 797-802.
[http://dx.doi.org/10.1016/j.jpeds.2008.12.045] [PMID: 19230904]
[7]
Sobouti B, Hooman N, Movahed M. The effect of vitamin E or vitamin A on the prevention of renal scarring in children with acute pyelonephritis. Pediatr Nephrol 2013; 28(2): 277-83.
[http://dx.doi.org/10.1007/s00467-012-2308-4] [PMID: 23052650]
[8]
Delshad M, Fesharakinia A, Eghbal S. The role of oxidative stress in pediatric urinary tract infections: A systematic review. Rev Clin Med 2016; 3(1): 43-7.
[9]
Allameh Z, Salamzadeh J. Use of antioxidants in urinary tract infection. J Res Pharm Pract 2016; 5(2): 79-85.
[http://dx.doi.org/10.4103/2279-042X.179567] [PMID: 27162800]
[10]
Jantausch BA, O’Donnell R, Wiedermann BL. Urinary interleukin-6 and interleukin-8 in children with urinary tract infection. Pediatr Nephrol 2000; 15(3-4): 236-40.
[http://dx.doi.org/10.1007/s004670000456] [PMID: 11149117]
[11]
Sheu J-N, Chen M-C, Lue K-H, et al. Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine 2006; 36(5-6): 276-82.
[http://dx.doi.org/10.1016/j.cyto.2007.02.006] [PMID: 17374489]
[12]
Hoberman A, Charron M, Hickey RW, Baskin M, Kearney DH, Wald ER. Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 2003; 348(3): 195-202.
[http://dx.doi.org/10.1056/NEJMoa021698] [PMID: 12529459]
[13]
Swerkersson S, Jodal U, Åhrén C, Hansson S. Urinary tract infection in small outpatient children: the influence of age and gender on resistance to oral antimicrobials. Eur J Pediatr 2014; 173(8): 1075-81.
[http://dx.doi.org/10.1007/s00431-014-2289-3] [PMID: 24623269]
[14]
Allameh Z, Karimi A, Rafiei Tabatabaei S, Sharifian M, Salamzadeh J. Effect of N-acetylcysteine on inflammation biomarkers in pediatric acute pyelonephritis: a randomized controlled trial. Iran J Kidney Dis 2015; 9(6): 454-62.
[PMID: 26552352]
[15]
Lunn J, Theobald H. The health effects of dietary unsaturated fatty acids. Nutr Bull 2006; 31(3): 178-224.
[http://dx.doi.org/10.1111/j.1467-3010.2006.00571.x]
[16]
Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol 2013; 75(3): 645-62.
[http://dx.doi.org/10.1111/j.1365-2125.2012.04374.x] [PMID: 22765297]
[17]
Sakai C, Ishida M, Ohba H, et al. Fish oil omega-3 polyunsaturated fatty acids attenuate oxidative stress-induced DNA damage in vascular endothelial cells. PLoS One 2017; 12(11)e0187934
[http://dx.doi.org/10.1371/journal.pone.0187934] [PMID: 29121093]
[18]
Anderson EJ, Thayne KA, Harris M, et al. Do fish oil omega-3 fatty acids enhance antioxidant capacity and mitochondrial fatty acid oxidation in human atrial myocardium via PPARγ activation.Mary Ann Liebert, Inc 3rd Floor New Rochelle, NY 10801 USA: Huguenot Street. 2014.
[19]
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352(16): 1685-95.
[http://dx.doi.org/10.1056/NEJMra043430] [PMID: 15843671]
[20]
Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6(10): 772-83.
[http://dx.doi.org/10.1038/nri1937] [PMID: 16998510]
[21]
Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21(6): 495-505.
[http://dx.doi.org/10.1080/07315724.2002.10719248] [PMID: 12480795]
[22]
Dalirani R, Yousefi Zoshk M, Sharifian M, et al. Role of vitamin A in preventing renal scarring after acute pyelonephritis. Iran J Kidney Dis 2011; 5(5): 320-3.
[PMID: 21876308]
[23]
Sedighi I, Solgi A, Amanati A, Alikhani MY. Choosing the correct empirical antibiotic for urinary tract infection in pediatric: Surveillance of antimicrobial susceptibility pattern of Escherichia coli by E-Test method. Iran J Microbiol 2014; 6(6): 387-91.
[PMID: 25926955]
[24]
Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 2000; 16(5): 861-5.
[http://dx.doi.org/10.1183/09031936.00.16586100] [PMID: 11153584]
[25]
Polito C, La Manna A, Rambaldi PF, Nappi B, Mansi L, Di Toro R. High incidence of a generally small kidney and primary vesicoureteral reflux. J Urol 2000; 164(2): 479-82.
[http://dx.doi.org/10.1016/S0022-5347(05)67404-6] [PMID: 10893627]
[26]
Fussell EN, Kaack MB, Cherry R, Roberts JA. Adherence of bacteria to human foreskins. J Urol 1988; 140(5): 997-1001.
[http://dx.doi.org/10.1016/S0022-5347(17)41909-4] [PMID: 2902235]
[27]
Şener G, Tuğtepe H, Velioğlu-Oğünç A, Çetinel S, Gedik N, Yeğen BÇ. Melatonin prevents neutrophil-mediated oxidative injury in Escherichia coli-induced pyelonephritis in rats. J Pineal Res 2006; 41(3): 220-7.
[http://dx.doi.org/10.1111/j.1600-079X.2006.00357.x] [PMID: 16948782]
[28]
Tullus K, Fituri O, Burman LG, Wretlind B, Brauner A. Interleukin-6 and interleukin-8 in the urine of children with acute pyelonephritis. Pediatr Nephrol 1994; 8(3): 280-4.
[http://dx.doi.org/10.1007/BF00866334] [PMID: 7917851]
[29]
Petrovic S, Bogavac-Stanojevic N, Kotur-Stevuljevic J, et al. Oxidative status parameters in children with urinary tract infection. Biochem Med (Zagreb) 2014; 24(2): 266-72.
[http://dx.doi.org/10.11613/BM.2014.029] [PMID: 24969920]
[30]
Kurutas EB, Ciragil P, Gul M, Kilinc M. The effects of oxidative stress in urinary tract infection. Mediators Inflamm 2005; 2005(4): 242-4.
[http://dx.doi.org/10.1155/MI.2005.242] [PMID: 16192676]
[31]
El-Salam M, Ibrahim GE-S, El-DesoukeyShiha A. Evaluation of antioxidant capacity and ascorbic acid in children with urinary tract infection. Available from: https://www.semanticscholar.org/paper/Evaluation-of-Antioxidant-Capacity-And-Ascorbic-In-El-Salam-Ibrahim/9a57a46d6494e929d2ff256940c9ebb60ae1b569
[32]
Pohl HG, Rushton HG, Park JS, Chandra R, Majd M. Adjunctive oral corticosteroids reduce renal scarring: the piglet model of reflux and acute experimental pyelonephritis. J Urol 1999; 162(3 Pt 1): 815-20.
[http://dx.doi.org/10.1097/00005392-199909010-00067] [PMID: 10458387]
[33]
Sharifian M, Anvaripour N, Karimi A, et al. The role of dexamethasone on decreasing urinary cytokines in children with acute pyelonephritis. 2008; 23(9): 1511.
[http://dx.doi.org/10.1007/s00467-008-0864-4]
[34]
Huang Y-Y, Chen M-J, Chiu N-T, Chou H-H, Lin K-Y, Chiou Y-Y. Adjunctive oral methylprednisolone in pediatric acute pyelonephritis alleviates renal scarring Pediatrics 2011; 2010-0297.
[http://dx.doi.org/10.1542/peds.2010-0297]
[35]
Tuğtepe H, Şener G, Çetinel S, Velioğlu-Oğünç A, Yeğen BÇ. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. Eur J Pharmacol 2007; 557(1): 69-75.
[http://dx.doi.org/10.1016/j.ejphar.2006.11.009] [PMID: 17173892]
[36]
Mittal R, Sharma S, Chhibber S, Harjai K. Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis. Microb Pathog 2008; 45(5-6): 323-30.
[http://dx.doi.org/10.1016/j.micpath.2008.08.003] [PMID: 18771720]
[37]
Zhang G-Q, Chen J-L, Zhao Y. The effect of vitamin A on renal damage following acute pyelonephritis in children: a meta-analysis of randomized controlled trials. Pediatr Nephrol 2016; 31(3): 373-9.
[http://dx.doi.org/10.1007/s00467-015-3098-2] [PMID: 25980468]
[38]
Schmidt EB, Pedersen JO, Varming K, et al. n-3 fatty acids and leukocyte chemotaxis. Effects in hyperlipidemia and dose-response studies in healthy men. Arterioscler Thromb 1991; 11(2): 429-35.
[http://dx.doi.org/10.1161/01.ATV.11.2.429] [PMID: 1998659]
[39]
Calder PC, Yaqoob P. Omega-3 polyunsaturated fatty acids and human health outcomes. Biofactors 2009; 35(3): 266-72.
[http://dx.doi.org/10.1002/biof.42] [PMID: 19391122]
[40]
Yamada H, Yoshida M, Nakano Y, et al. In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arterioscler Thromb Vasc Biol 2008; 28(12): 2173-9.
[http://dx.doi.org/10.1161/ATVBAHA.108.171736] [PMID: 18948636]
[41]
Hajianfar H, Paknahad Z, Bahonar A. The effect of omega-3 supplements on antioxidant capacity in patients with type 2 diabetes. Int J Prev Med 2013; 4(Suppl. 2): S234-8.
[PMID: 23776730]
[42]
D’Auria E, Miraglia Del Giudice MM, Barberi S, Eds. Omega-3 fatty acids and asthma in children. Allergy Asthma Proc 2014; 35(13): 233-40.
[http://dx.doi.org/10.2500/aap.2014.35.3736] [PMID: 24801466]
[43]
Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2011; 50(10): 991-1000.
[http://dx.doi.org/10.1016/j.jaac.2011.06.008] [PMID: 21961774]
[44]
Bent S, Bertoglio K, Hendren RL. Omega-3 fatty acids for autistic spectrum disorder: a systematic review. J Autism Dev Disord 2009; 39(8): 1145-54.
[http://dx.doi.org/10.1007/s10803-009-0724-5] [PMID: 19333748]
[45]
Barragán E, Breuer D, Döpfner M. Efficacy and safety of omega-3/6 fatty acids, methylphenidate, and a combined treatment in children with ADHD. J Atten Disord 2017; 21(5): 433-41.
[http://dx.doi.org/10.1177/1087054713518239] [PMID: 24464327]
[46]
Chang C-H, Tseng P-T, Chen N-Y, et al. Safety and tolerability of prescription omega-3 fatty acids: A systematic review and meta-analysis of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids 2018; 129: 1-12.
[http://dx.doi.org/10.1016/j.plefa.2018.01.001] [PMID: 29482765]
[47]
Nejatinamini S, Ataie-Jafari A, Ghasemian A, et al. Burden of ischemic heart disease attributable to low omega-3 fatty acids intake in Iran: Findings from the global burden of disease study 2010. J Tehran Univ Heart Cent 2016; 11(1): 21-9.
[PMID: 27403186]

Rights & Permissions Print Cite
Article Metrics
14
1
© 2024 Bentham Science Publishers | Privacy Policy